What Causes Transverse Myelitis And How Its Treated?

Transverse myelitis is inflammation of the spinal cord that damages the protective myelin covering nerve fibers and interrupts signals traveling between the brain and the body. It causes rapid onset of weakness, numbness, and bladder or bowel problems, usually over hours to days. Most cases are triggered by an abnormal immune response, sometimes after an infection, and are treated first with high-dose corticosteroids to calm that inflammation.

What Causes Transverse Myelitis And How Is It Treated?

In most cases, the immune system attacks the spinal cord by mistake. The body’s defense cells, which normally target viruses and bacteria, instead recognize myelin in the spinal cord as foreign and launch an inflammatory attack on it. This is called an autoimmune response, and it is the underlying mechanism in the majority of confirmed cases.

Doctors divide causes into a few broad groups. Knowing which group applies matters, because it changes both the treatment and the outlook.

• Post-infectious: A prior infection triggers an immune response that cross-reacts with spinal cord tissue. This is one of the most commonly identified patterns.
• Multiple sclerosis and related conditions: Transverse myelitis can be the first sign of MS or a related demyelinating disease such as neuromyelitis optica spectrum disorder (NMOSD) or MOG antibody disease.
• Systemic autoimmune disease: Conditions such as lupus and Sjögren’s syndrome can involve the spinal cord.
• Direct infection or other causes: Less often, an infection, a vascular problem, or a tumor compresses or damages the cord in ways that can mimic myelitis.

Here is a point that surprises many people. A large share of cases are labeled idiopathic, meaning no specific cause is ever found. That label does not mean nothing is wrong. It means the standard tests did not identify a trigger. Research published in Neurology has described idiopathic cases as a substantial portion of the total.

Treatment begins with reducing the inflammation. High-dose intravenous corticosteroids, typically given over several days, are the standard first-line approach. Some clinicians add plasma exchange, a procedure that filters antibodies from the blood, when steroids do not produce enough improvement or when a specific antibody-mediated condition like NMOSD is suspected. The evidence for plasma exchange is stronger in those antibody-associated conditions than in idiopathic cases. After the acute phase, care focuses on rehabilitation to recover function, plus treating any identified underlying disease.

What Are the First Symptoms of Transverse Myelitis?

Symptoms usually appear quickly, over hours to a few days, and then worsen. The speed of onset is one of the features that helps distinguish it from slower, degenerative spinal cord problems.

The most common early complaints are numbness or tingling in the legs, a band-like sensation around the chest or abdomen, and weakness in the legs. Many people also develop bladder urgency or difficulty urinating. Some notice sharp pain in the back or limbs before the weakness begins.

Because the inflammation typically affects a segment of the cord, symptoms often have a clear “level.” A person may feel normal above a certain point on the torso and have numbness or weakness below it. This sensory level is a classic finding doctors look for on examination.

Symptoms on both sides of the body are typical, which helps separate transverse myelitis from some other nerve conditions. The word “transverse” refers to inflammation that extends across the width of the spinal cord.

How Is Transverse Myelitis Diagnosed?

Diagnosis rests on a combination of clinical findings and imaging, and the first step is often ruling out other causes of spinal cord dysfunction. A compressed cord from a disc or tumor, a stroke of the spinal cord, and certain infections can produce similar symptoms but require very different treatment.

Magnetic resonance imaging (MRI) of the spine is the key test. It can show inflammation within the cord and help locate the affected segment. A lumbar puncture, also called a spinal tap, is often performed to examine the cerebrospinal fluid for signs of inflammation and to test for infections.

Blood tests help look for underlying autoimmune conditions, including antibodies associated with NMOSD and MOG antibody disease. These antibody tests have changed how doctors classify and treat spinal cord inflammation, because some antibody-positive cases need different therapy than typical MS-related cases.

Doctors may also use a set of established diagnostic criteria to confirm the diagnosis and exclude mimics. These criteria generally require symptoms consistent with spinal cord dysfunction, imaging or laboratory evidence of inflammation, and the exclusion of other explanations. No single test confirms transverse myelitis on its own.

How Is Transverse Myelitis Treated?

Treatment has two distinct phases: calming the acute inflammation and then supporting recovery. The first phase is time-sensitive, which is why rapid medical evaluation matters.

For the acute phase, intravenous high-dose corticosteroids are the standard first-line treatment. The goal is to reduce swelling and immune attack on the cord. If steroids do not work well enough, or if a specific antibody-mediated condition is suspected, plasma exchange may be used. Some clinicians also use intravenous immunoglobulin in certain situations, though the evidence for it is less established than for steroids and plasma exchange.

Once the acute inflammation is addressed, rehabilitation becomes central. Physical therapy helps rebuild strength and walking ability. Occupational therapy focuses on daily tasks. Bladder and bowel management is often needed, and a urology referral can help.

Recovery varies widely. Some people regain most function, while others have lasting weakness, sensory changes, or bladder problems. The degree of recovery depends on how much damage occurred and how quickly treatment started. It is not possible to predict an individual’s outcome from the diagnosis alone.

If an underlying condition such as MS, NMOSD, or lupus is identified, long-term treatment targets that disease. This is why the diagnostic workup continues even after the acute episode is treated.

What Is the Recovery and Outlook Like?

Recovery is gradual and often continues for months. Most improvement happens in the first several months after the attack, but some people continue to gain function for a year or longer. The pace and ceiling of recovery differ from person to person.

Some people recover fully. Others are left with ongoing symptoms such as stiffness, fatigue, altered sensation, or bladder control problems. A smaller group has significant lasting disability. Because outcomes are so variable, doctors generally avoid firm predictions early on and instead monitor progress over time.

Rehabilitation is not a minor add-on. Consistent physical and occupational therapy is strongly associated with better functional outcomes, and it addresses the practical problems that matter most, like walking safely and managing daily activities. Mental health support is also worth considering, since a sudden neurological event can be frightening and disruptive.

Can Transverse Myelitis Be Prevented?

There is no proven way to prevent transverse myelitis. Because most cases arise from an unpredictable immune response, there is no lifestyle change or vaccine that has been shown to prevent it.

What can be done is early recognition. Rapid evaluation of new weakness, numbness, or bladder problems allows treatment to start sooner, and earlier treatment is generally thought to improve the chance of recovery. This is a reasonable inference from how inflammatory damage works, though the direct evidence on timing in transverse myelitis specifically is limited.

For people with a known autoimmune condition such as MS or NMOSD, staying on prescribed disease-modifying therapy is important, because untreated disease activity can involve the spinal cord. Decisions about treatment should always be made with a neurologist.